Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter

NCT04149535 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04149535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04149535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
February 7, 2020
Completion date
February 1, 2022
Enrollment
3,000 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

stroke